News
A team of health experts is launching an independent project that could start its own vaccine evaluation and guidelines — ...
CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA ...
Wildfire smoke exposure acutely increased IL-13 expression in NK cells and was negatively associated with COVID-19 vaccine immunity.
On a recent call with analysts at BMO Capital Markets, a “former director” at the FDA’s Center for Biologics Evaluation and ...
Pfizer and BioNTech have formally asked for FDA approval of a third dose of their COVID-19 vaccine BNT162b2 in people aged over 16, as the US prepares to get its booster campaign underway.
GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ...
Recent CDC figures suggest that fewer than 40% of people aged over 65 have opted for a bivalent booster shot, at a time when COVID-19 cases have risen sharply in the US with around 67,000 new ...
According to the US' CDC, the ongoing clade II 2022 mpox outbreak has been responsible for over 100,000 infections in 122 countries to date worldwide.
US CDC advisers discuss narrowing use of COVID-19 booster shots The U.S. Centers ... GSK resolves patent lawsuit against Pfizer over RSV vaccines British pharmaceutical giant GlaxoSmithKline ...
Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...
1d
Zacks.com on MSNSanofi Q1 Earnings Top Estimates, Dupixent Drives Sales GrowthSanofi SNY reported first-quarter 2025 adjusted earnings of 94 cents per American depositary share, which beat the Zacks Consensus Estimate of 90 cents per share. Earnings of €1.79 per share rose 17.0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results